Vertex Pharmaceuticals Incorporated (BVMF:VRTX34)

Vertex Pharmaceuticals Ratios and Metrics

Market cap in millions BRL. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 26, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	647,618	633,563	641,418	508,757	391,882	311,089
Market Cap Growth	-3.58%	-1.23%	26.07%	29.82%	25.97%	-2.53%
Enterprise Value	594,847	577,519	582,946	446,243	344,587	277,190
Last Close Price	616.11	625.92	617.48	495.88	382.28	309.16
PE Ratio	29.74	29.10	-	28.97	22.31	23.84
PS Ratio	9.80	9.58	9.41	10.62	8.30	7.37
PB Ratio	6.30	6.16	6.32	5.96	5.33	5.53
P/TBV Ratio	6.85	6.71	7.15	6.70	6.07	6.42
P/FCF Ratio	36.81	36.02	-	31.42	18.89	23.18
P/OCF Ratio	32.38	31.68	-	29.64	17.95	21.12
EV/Sales Ratio	9.66	8.74	8.55	9.32	7.30	6.57
EV/EBITDA Ratio	22.68	21.55	20.59	20.54	14.40	12.38
EV/EBIT Ratio	24.73	22.37	21.45	21.35	14.89	12.78
EV/FCF Ratio	33.81	32.83	-	27.56	16.61	20.66
Debt / Equity Ratio	0.11	0.11	0.11	0.05	0.07	0.10
Debt / EBITDA Ratio	0.40	0.40	0.37	0.18	0.20	0.24
Debt / FCF Ratio	0.64	0.64	-	0.24	0.23	0.40
Net Debt / Equity Ratio	-0.55	-0.55	-0.58	-0.73	-0.72	-0.65
Net Debt / EBITDA Ratio	-2.11	-2.11	-2.07	-2.88	-2.21	-1.63
Net Debt / FCF Ratio	-3.22	-3.22	11.99	-3.87	-2.54	-2.72
Asset Turnover	0.50	0.50	0.49	0.48	0.57	0.60
Inventory Turnover	3.85	3.85	5.31	7.38	8.87	8.97
Quick Ratio	2.24	2.24	2.17	3.60	4.46	4.04
Current Ratio	2.90	2.90	2.69	3.99	4.83	4.46
Return on Equity (ROE)	22.54%	22.54%	-3.15%	22.99%	27.67%	24.93%
Return on Assets (ROA)	12.16%	12.16%	12.14%	13.17%	17.33%	19.32%
Return on Invested Capital (ROIC)	29.60%	30.54%	-98.60%	63.54%	90.72%	102.53%
Return on Capital Employed (ROCE)	21.50%	21.50%	23.20%	22.50%	28.40%	34.50%
Earnings Yield	3.36%	3.44%	-0.52%	3.45%	4.48%	4.20%
FCF Yield	2.72%	2.78%	-0.76%	3.18%	5.29%	4.31%
Buyback Yield / Dilution	-0.04%	-0.04%	1.00%	-0.54%	0.31%	1.33%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.